Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.

BACKGROUND: Vaccination with a recombinant modified vaccinia Ankara expressing antigen 85A from Mycobacterium tuberculosis, MVA85A, induces high levels of cellular immune responses in UK volunteers. We assessed the safety and immunogenicity of this new vaccine in West African volunteers. METHODS AND...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Brookes, R, Hill, A, Owiafe, P, Ibanga, H, Jeffries, D, Donkor, SA, Fletcher, H, Hammond, A, Lienhardt, C, Adegbola, R, McShane, H
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	Public Library of Science 2008

Ижил төстэй зүйлс

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
-н: Roger H Brookes, зэрэг
Хэвлэсэн: (2008-08-01)

Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa.
-н: Roger H. Brookes, зэрэг
Хэвлэсэн: (2011-01-01)

Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design.
-н: Ibanga, H, зэрэг
Хэвлэсэн: (2006)

Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
-н: Owiafe, P, зэрэг
Хэвлэсэн: (2012)

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
-н: Ota, M, зэрэг
Хэвлэсэн: (2011)

Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
-н: Ota, M, зэрэг
Хэвлэсэн: (2011)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
-н: Pathan, A, зэрэг
Хэвлэсэн: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
-н: Pathan, A, зэрэг
Хэвлэсэн: (2012)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
-н: Meyer, J, зэрэг
Хэвлэсэн: (2013)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
-н: Mcshane, H, зэрэг
Хэвлэсэн: (2005)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
-н: Whelan, K, зэрэг
Хэвлэсэн: (2009)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
-н: Meyer, J, зэрэг
Хэвлэсэн: (2013)

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
-н: Rowland, R, зэрэг
Хэвлэсэн: (2012)

The effect of tuberculin skin test and BCG vaccination on the expansion of PPD-specific IFN-gamma producing cells ex vivo.
-н: Ota, M, зэрэг
Хэвлэсэн: (2007)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
-н: Harris, S, зэрэг
Хэвлэсэн: (2011)

Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa
Хэвлэсэн: (2011-01-01)

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.
-н: White, A, зэрэг
Хэвлэсэн: (2013)

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults
-н: Minassian, A, зэрэг
Хэвлэсэн: (2011)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
-н: Hawkridge, T, зэрэг
Хэвлэсэн: (2008)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection
-н: Betts, G, зэрэг
Хэвлэсэн: (2012)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
-н: Kathryn T. Whelan, зэрэг
Хэвлэсэн: (2011-01-01)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
-н: Sander, C, зэрэг
Хэвлэсэн: (2009)

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.
-н: Rowland, R, зэрэг
Хэвлэсэн: (2013)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
-н: Tameris, M, зэрэг
Хэвлэсэн: (2014)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
-н: Thomas, Z, зэрэг
Хэвлэсэн: (2014)

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
-н: Minhinnick, A, зэрэг
Хэвлэсэн: (2016)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
-н: Odutola, A, зэрэг
Хэвлэсэн: (2012)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
-н: Odutola, A, зэрэг
Хэвлэсэн: (2012)

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.
-н: Fletcher, H, зэрэг
Хэвлэсэн: (2008)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
-н: Wajja, A, зэрэг
Хэвлэсэн: (2017)

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.
-н: Griffiths, K, зэрэг
Хэвлэсэн: (2011)

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel mycobacterium tuberculosis vaccine MVA85A
-н: Griffiths, K, зэрэг
Хэвлэсэн: (2011)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.
-н: Gareth Betts, зэрэг
Хэвлэсэн: (2012-01-01)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
-н: Harris, S, зэрэг
Хэвлэсэн: (2013)

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults
-н: Riste, M, зэрэг
Хэвлэсэн: (2021)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
-н: Tameris, M, зэрэг
Хэвлэсэн: (2014)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial
-н: Satti, I, зэрэг
Хэвлэсэн: (2014)

A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults
-н: Wilkie, M, зэрэг
Хэвлэсэн: (2019)

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naive subjects gives comparable immunogenicity to one dose in ART+ subjects
-н: Dieye, T, зэрэг
Хэвлэсэн: (2013)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
-н: Mcshane, H
Хэвлэсэн: (2008)